Tag: psychosis

Emerging Schizophrenia Drugs Target Negative Symptoms

Late-stage trials of new antipsychotic drugs are showing promise in the control of negative symptoms, according to an overview presented by Current Psychiatry and the...

Anticholinergics a Key Contributor to Cognitive Impairment

Anticholinergic medication burden from antipsychotics, antidepressants, and other psychotropics has a cumulative effect of worsening cognitive function in patients with schizophrenia, new research indicates. “The...

Increased Risk for Suicide, Self-harm in ICU Survivors

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Critically ill adults who survive a stint in the intensive care...

Blood Biomarker a ‘Promising Predictor’ of Psychosis Relapse

Copeptin, a small peptide secreted with the hormone vasopressin, appears to be one of the first promising biomarkers for predicting psychosis relapse, results of an...

Motor Abnormalities a Harbinger of Serious Mental Illness?

Motor problems in children may be a harbinger of serious mental illness, new research suggests. Investigators found that motor abnormalities were twice as common among...

Potential First-in-Class Schizophrenia Drug Cuts Negative Symptoms

The novel antipsychotic agent SEP-363856 (Sunovion Pharmaceuticals) has a significant and ongoing effect on negative symptoms in patients with schizophrenia, new research shows. Results of...

Dementia: What Is Dementia-Related Psychosis?

More than 2 million Americans have dementia-related psychosis. If you have a loved one who has dementia, you know that it can be a scary...

Recognizing Psychotic Symptoms of Dementia

Many of the 50 million people or so who are living with dementia also have psychosis. You may hear doctors use the term “psychotic episodes.”...

Delusional Infestation Surges During COVID-19 Pandemic

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Psychiatrists with expertise in delusional infestation have some advice for dermatologists,...

Billions of Years Old, Lithium Still Has a Promising Future

In a six-decade career spent researching and prescribing lithium ― a long-established therapy for bipolar disorder ― psychiatrist David Dunner, MD, has many stories about...

Global Experts Map the Latest in Bipolar Management

A new monograph offers a far-reaching update on research and clinical management of bipolar disorders (BDs), including epidemiology, genetics, pathogenesis, psychosocial aspects, and current and...

The Future of Psychedelic Therapy in the US

After a 50-year hiatus, psychedelic drugs are undergoing a research renaissance. Roland R. Griffiths, professor in the Departments of Psychiatry and Neuroscience and the Oliver...

Breathing Enriched Oxygen May Improve Major Depression

Breathing enriched oxygen on a nightly basis may lead to clinically meaningful symptomatic improvement in mild to moderate major depression, new research suggests. Dr R....

Girls with ADHD at High Risk for Self-Injury

Recent studies constitute a clarion call for clinicians to routinely screen adolescents with ADHD for nonsuicidal self-injury (NSSI) and its risk factors, Judit Balazs, MD,...

No Need for Antipsychotics to Recover?

Two new studies highlight the importance of early intervention in first-episode psychosis (FEP). In the first study, Australian investigators conclude that for some FEP patients,...

ED Visits for Mental Health, Substance Use Doubled in One Decade

Emergency department (ED) visits related to mental health conditions increased nearly twofold from 2007–2008 to 2015–2016, new research suggests. Data from the National Hospital Ambulatory...

LAIs vs Usual Care for First Hospitalization in Early Psychosis

Treatment with a long-acting injectable antipsychotic (LAI) in early-phase schizophrenia can significantly delay time to first hospitalization, new research suggests. The Prevention of Relapse in...

ECT More Effective for Psychotic vs Nonpsychotic Depression?

For patients with psychotic depression, response to treatment, remission rates, and cognitive improvement are better following electroconvulsive therapy (ECT) than for patients with nonpsychotic depression,...

New Insight into Neurobehavioral Effects of Legalized Cannabis

Researchers have published one of the first studies to characterize the association between the consumption of legal cannabis and subsequent pharmacologic and neurobehavioral outcomes, with...

COVID-19 and Psychosis: Is There a Link?

Since the start of the COVID-19 pandemic, most of the research into the SARS-CoV-2 virus has focused on its direct effects on the body with...